Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411641 | PMC |
| http://dx.doi.org/10.1002/jgh3.12351 | DOI Listing |
Publication Analysis
Top Keywords
shunt occlusion
12
occlusion prior
8
prior lenvatinib
8
lenvatinib administration
8
hepatic encephalopathy
8
administration prevents
4
prevents hepatic
4
encephalopathy hyperammonemia
4
hyperammonemia shunt
4
administration prevented
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!